Skip to main content

ADVERTISEMENT

Bladder Cancer

News
01/14/2020
A retrospective analysis shows that laparoscopic nephroureterectomy can benefit patients with bladder cancer because of minimal invasiveness and comparable outcomes with open nephroureterectomy.
A retrospective analysis shows that laparoscopic nephroureterectomy can benefit patients with bladder cancer because of minimal invasiveness and comparable outcomes with open nephroureterectomy.
A retrospective analysis shows...
01/14/2020
Oncology
News
01/14/2020
Patients with muscle-invasive bladder cancer who are more likely to receive neoadjuvant vs adjuvant chemo have a higher rate of OS.
Patients with muscle-invasive bladder cancer who are more likely to receive neoadjuvant vs adjuvant chemo have a higher rate of OS.
Patients with muscle-invasive...
01/14/2020
Oncology
News
01/10/2020
When compared with trimodal therapy, radical cystectomy was tied to a significant reduction in all-cause mortality in patients with non–organ-confined bladder cancer.
When compared with trimodal therapy, radical cystectomy was tied to a significant reduction in all-cause mortality in patients with non–organ-confined bladder cancer.
When compared with trimodal...
01/10/2020
Oncology
News
01/10/2020
Combining THOLR or TUR with intravesical epirubicin within 24 hours of surgery has been shown to be safe and effective for the treatment of patients with bladder cancer tumors.
Combining THOLR or TUR with intravesical epirubicin within 24 hours of surgery has been shown to be safe and effective for the treatment of patients with bladder cancer tumors.
Combining THOLR or TUR with...
01/10/2020
Oncology
News
01/08/2020
Avelumab significantly prolonged OS in patients with urothelial cancer, according to data from a planned interim analysis of the JAVELIN Bladder 100 study.
Avelumab significantly prolonged OS in patients with urothelial cancer, according to data from a planned interim analysis of the JAVELIN Bladder 100 study.
Avelumab significantly prolonged...
01/08/2020
Oncology
Test Your Knowledge
01/06/2020
True or False: Education and rehabilitation programs have shown no benefits in the post-surgery management of patients with muscle-invasive bladder cancer.
True or False: Education and rehabilitation programs have shown no benefits in the post-surgery management of patients with muscle-invasive bladder cancer.
True or False: Education and...
01/06/2020
Oncology
Test Your Knowledge
12/20/2019
Study findings suggest that the novel long non-coding (lnc)RNA KMU15 could _____ the proliferation and progression of bladder cancer.
Study findings suggest that the novel long non-coding (lnc)RNA KMU15 could _____ the proliferation and progression of bladder cancer.
Study findings suggest that the...
12/20/2019
Oncology
Test Your Knowledge
12/20/2019
True or False: Urinary calprotectin cannot be used as a specific tumor marker for bladder cancer.
True or False: Urinary calprotectin cannot be used as a specific tumor marker for bladder cancer.
True or False: Urinary...
12/20/2019
Oncology
Test Your Knowledge
12/19/2019
True or False: The interaction between YAP1 and mTOR slows down disease progression in patients with bladder cancer.
True or False: The interaction between YAP1 and mTOR slows down disease progression in patients with bladder cancer.
True or False: The interaction...
12/19/2019
Oncology
News
12/18/2019
Study results suggest that the novel long non-coding RNA KMU15 could promote the proliferation and progression of bladder cancer.
Study results suggest that the novel long non-coding RNA KMU15 could promote the proliferation and progression of bladder cancer.
Study results suggest that the...
12/18/2019
Oncology